Is This the End of Compounded GLP-1 Medications?

As the demand for GLP-1 medications continues to grow, compounded versions of semaglutide and tirzepatide have gained attention as alternatives to brand-name drugs like Wegovy, Ozempic, Mounjaro, and Zepbound. These compounded medications have provided access for individuals unable to secure or afford the original brands. However, recent FDA actions suggest that compounded GLP-1 medications may soon be phased out. This article explores why these compounded options are being produced, the regulatory and economic issues surrounding them, who manufactures these versions, and what patients should do if compounded GLP-1 medications become unavailable.

Why Are Compounded Semaglutide and Compounded Tirzepatide So Popular?

GLP-1 medications like Wegovy and Zepbound have been in high demand since their weight loss effects gained widespread attention. They have garnered a strong following not only among those managing chronic weight-related conditions but also among wealthy individuals and celebrities looking for a quick and easy way to lose a few pounds. This popularity has led to increased demand for these medications, creating supply shortages.

Compounded semaglutide and compounded tirzepatide have become highly popular because they provide an affordable, accessible alternative to the brand-name medications. While compounded versions have provided a workaround, especially when the brand-name drugs have been costly or unavailable, this demand has also contributed to a heated supply chain, where compounded semaglutide and tirzepatide are often in high demand even as their production faces new regulatory restrictions.

Who Makes Compounded GLP-1 Medications?

Compounded GLP-1 medications are primarily produced by 503B compounding pharmacies, which are legally allowed to create these products in response to drug shortages. These pharmacies operate under FDA-approved guidelines, though the production processes and testing requirements differ from the rigorous standards applied to brand-name medications produced by companies like Novo Nordisk and Eli Lilly​. The active ingredients used by these compounding pharmacies are sourced from overseas suppliers, mainly in China, and imported to the U.S. for further compounding. However, since these compounding facilities are not affiliated with the brand-name manufacturers, their products have not undergone the same level of safety testing​.

Why Compounded GLP-1 Medications May Soon Be Phased Out

As the supply of Zepbound and Wegovy stabilizes, the FDA’s regulations are shifting. Since compounded versions of these drugs only became legal under the condition of drug shortages, the current change in supply status affects their legality. Once the shortages are resolved, producing compounded versions becomes a patent infringement. Both Novo Nordisk and Eli Lilly have made it clear that they intend to pursue aggressive legal action against compounding pharmacies or providers that attempt to continue distributing compounded GLP-1 medications without proper authorization​​.

A Temporary “Stay of Execution”

While the FDA initially signaled (October 2024) that compounded tirzepatide would soon be removed from the market, a recent legal challenge has delayed this. The Alliance for Pharmacy Compounding filed a lawsuit against the FDA, arguing that ending compounded production prematurely would create access issues for the many patients who still rely on these medications. A federal court responded with a temporary “stay of execution,” allowing compounded tirzepatide to remain available until further review. This court decision has offered some relief to those concerned about losing access but is unlikely to represent a long-term solution​.

Do I have coverage for GLP-1 Medications?

.jotform-iframe { min-width:100%; max-width:100%; border:none; padding:0px; @media only screen and (max-width: 768px) { min-height:670px; height:670px; } @media only screen and (min-width: 769px) { min-height:600px; height:600px; }

window.jotformEmbedHandler(“iframe[id=’JotFormIFrame-242157067624154’]”, “https://form.jotform.com/”)

How Long Will Compounded GLP-1 Medications Be Available?

The length of time compounded GLP-1 medications will remain available depends on the outcome of ongoing legal proceedings and the FDA’s final determination. However, if Eli Lilly and Novo Nordisk can meet the demand for their brand-name drugs, compounded versions may indeed be discontinued in the near future.

If Compounded GLP-1 Medications Are Unavailable, What Are Your Options?

If compounded GLP-1 medications are no longer available, patients may need to explore other options to manage obesity or Type 2 diabetes.

1. Contact Your Healthcare Provider

If compounded options disappear, consulting with your healthcare provider should be the first step. They may have access to new brand-name versions, or they may recommend alternatives such as GLP-1 medications in lower doses or different forms, such as vials instead of injectors, to help meet specific dosage needs​.

2. Seek Out Insurance Support for Brand-Name Options

For those concerned about the cost of brand-name GLP-1 medications, working with your healthcare provider to secure insurance approval is a critical next step. Many healthcare practices now have support programs to help patients with the insurance process, advocating for coverage of medications like Wegovy and Ozempic​. If your healthcare provider doesn’t offer this, you can use our “Determine Your Coverage” questionnaire to guide you through the process with your insurance company. 

3. Brand-Name Medications Cost Less Using Creative Dosing Strategies

At Pound of Cure Weight Loss, we offer our Platinum Program which is designed to make brand-name GLP-1 medications like Wegovy and Zepbound affordable by employing creative dosing strategies that can significantly lower the cost—often making these premium options less expensive than compounded alternatives. 

Through personalized, carefully managed dosing schedules, we optimize each prescription while reducing overall expense. This approach allows you to benefit from the quality and safety of brand-name GLP-1s without the steep costs typically associated with them. The Platinum Program is available to anyone in the United States and provides not only affordable access but also hands-on support from our experienced team, ensuring you can reach your weight loss goals.

4. Adjust Your Diet and Lifestyle

The Pound of Cure Nutrition Program centers on a whole-food approach with fruits, vegetables, nuts, seeds, lean proteins, beans, and legumes. Adjusting to this plan can support weight loss and metabolic health even in the absence of GLP-1 medications. Combining this dietary focus with regular physical activity and lifestyle adjustments can further enhance weight management and health outcomes​​.

5. Consider Bariatric Surgery

Bariatric surgery presents a highly effective and durable alternative for achieving significant weight loss. Unlike medications, which require ongoing access and cost, bariatric surgery is a one-time procedure. Studies show that the weight loss from bariatric surgery is often more sustainable over time compared to medication alone because the surgery fundamentally changes the body’s metabolic processes, effectively lowering the metabolic “set point” that governs body weight. 

Modern bariatric procedures, like gastric bypass and sleeve gastrectomy, are now safer than ever, with low complication rates and highly reliable outcomes. With the support of a comprehensive nutrition and lifestyle program, bariatric surgery offers a powerful, lasting solution for weight loss.

The Future of GLP-1 Medications: Brand-Name Options as the Norm?

As compounding pharmacies face stricter regulations, it’s likely that patients will need to shift toward brand-name GLP-1 medications exclusively. This shift could come with higher costs and more limited access, but the FDA’s actions emphasize a commitment to safety and quality. While compounded medications have been beneficial for many, brand-name GLP-1 medications offer tested, reliable options that meet rigorous standards.

Conclusion

The potential end of compounded GLP-1 medications signals a change in the weight management landscape. Although compounded semaglutide and compounded tirzepatide may have offered accessible options during a time of shortage, the return of brand-name supplies points toward a future where only regulated, patent-compliant options will be available. Whether you’re currently using compounded versions or considering brand-name options, planning your next steps now will ensure you’re prepared for any upcoming changes.

The Pound of Cure Platinum Program

To help you get access to expert weight loss care, and GLP-1 medications in the most cost-efficient way possible,  we created the Pound of Cure Platinum Program.

Our program allows most patients to save at least 50% (and often more) off the cost of their GLP-1 medications. Our program allows you to use real GLP-1 medications (not compounded), and takes advantage of inefficiencies in our medication pricing system.

Sign up for our free webinar

The Platinum Program allows you unlimited access to Dr. Weiner and Zoe to ensure that your medications are prescribed to maximize weight loss efficiency and minimize side effects. You can meet with Zoe as often as you’d like to ensure that you’re also making the important nutritional changes necessary for long term success and comfort.

The Pound of Cure team will be fully dedicated to your success and do everything possible to help you change your lifestyle and obtain any medications necessary in the safest and most affordable way.

The Pound of Cure Platinum Program Includes

• Unlimited visits and portal messages with Dr. Weiner without additional copays or charges
• Unlimited group and individual sessions with Zoe
• Any prescriptions necessary and guidance on how to reduce your prescriptions costs
• Access to our insurance concierge service for GLP-1 medication coverage if you want to use your insurance
• Access to the Pound of Cure Weight Loss app that includes Sage, an AI dietitian trained to create meal plans and recipes based on your food preferences
• Access to our unique caloratio food logging system

Pricing

• It’s simple. Get started with a $75 consult. No surprises. No commitment if you decide not to continue.

Your Initial Consultation Includes:

• Your visit with Dr. Weiner
• Review of medical history
• Personalized treatment plan
• Credit towards your program fee if you choose to continue
• No surprise bills

If You Choose To Move Forward:

• $129/month for the first six months and then $59/month
• Most patients are able to access GLP-1 medications for between $150-$300/month
• $99 rejoin fee for past members
• Cost does not include medication